2004, Number S3
<< Back Next >>
Gac Med Mex 2004; 140 (S3)
RISK TRANSFUSIONAL FOR TRANSMISSIBLE DISEASES
I. Contagious diseases I strike and history
Escamilla-Guerrero G
Language: Spanish
References: 11
Page: 69-70
PDF size: 28.38 Kb.
Text Extraction
No abstract
REFERENCES
“Guerra de la sangre” en historia de la sangre, Starr Douglas. pp 81-198.1ed. enero 2000.
“Germ, geles, and genomes” by Y. Dood R. in Blood Safety in the New Millennium by Strammer Sussan L. AABB 2a Ed. Bethesda, Maryland (USA). 2001 pp 97-118.
Tegtmeier GE, Parks LH, Blosser JK. “Hepatitis markers in blood donors with a history of hepatitis or jaundice. Transfusion 1991:31:64S.
Blumberg BS, Gerstleuy BJS, Hungerford DA. A ferum antigen (Australia antigen) in Down‘s syndrome, leukemia and hepatitis. Ann Intern Med. 1967;66:924-928.
Ling CM, Overby LR. Revlence of Hepatitis B virus antigen as revealed by direct radio immune assay with 125-I-antibody. J. Immunol. 1972;109:834-840.
Aach RD, Szmuness W, Mosley JW. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. The Transfusion-Transmitted Viruses Study. N. Engl. J. Med. 1981;304:989-994.
Koziol DE, Hollan PV, Alling DW. Antibody to hepaitis B core antigen as a paradoxical marker for non-a non –b hepatitis agents in donated blood. Ann Intern Med. 1986:104:488-495.
Choo QL, Kuo G, Wiener AJ. Isolation of a cDNA clone derived from a blood –borne non-A non-B hepatitis genome. Science.1989; 244:362-364.
Kuo G, Choo QL, Alter HJ. An assay for circulating antibodies to a major etiologic virus of human non-A non-B hepatitis. Science 1989;244:362-364.
Strramer SL, Caglioti S, Strong DM. NAT of the United States and Canadian Blood supply. Transfusion 2000, 40:1164-1167.
Murthy KK, Henrard DR, Eichberg JW. Redefining the HIV infectious window period in the chimpanzee model: Evidence to suggest that viral nucleic acid testing can prevent blood-borne transmission. Transfusion 199; 39:688-693.
Full text